UBC scientists find new way to mobilize immune system against viruses
Key points
- University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop a new treatment against harmful viruses.
- A key element to this natural immune response is an antiviral protein in the blood called Interferon alpha.
- After the job of Interferon alpha is done, MMP12 dissolves the protein during the healing process.
- Overall has developed a new antiviral drug that blocks MMP12 from dissolving Interferon alpha outside the cell, giving the immune system an added boost by keeping levels of the protein high in the bloodstream.
University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop a new treatment against harmful viruses.
Viral pandemics, such as the coronavirus that caused the deadly SARS outbreak in 2002, have caused hundreds of deaths in Canada, yet effective anti-viral drugs are rare.
headshot_overall
A key element to this natural immune response is an antiviral protein in the blood called Interferon alpha. Like soldiers, Interferon alpha is quickly deployed by the body to fight viruses and removed just as quickly to restore equilibrium.
As described in the current issue of the prestigious journal Nature Medicine, a team led by Overall from UBC’s Department of Oral Biological and Medical Sciences and Bruce McManus from UBC’s Department of Pathology and Laboratory Medicine has discovered that an enzyme called MMP12 serves double-duty in the deployment of the critical antiviral protein: it first enters the infected cell to activate Interferon alpha and then sends it outside the cell membrane to fight viruses. After the job of Interferon alpha is done, MMP12 dissolves the protein during the healing process.
Overall has developed a new antiviral drug that blocks MMP12 from dissolving Interferon alpha outside the cell, giving the immune system an added boost by keeping levels of the protein high in the bloodstream. The drug cannot penetrate cell membranes, making it unable to interfere with the beneficial work inside the cell. The drug has been shown to effectively treat viral infections in mice models and holds promise as a new broad-spectrum antiviral treatment.
“Because the drug isn’t virus-strain specific and boosts the body’s own immune response to fight infections, it could be effective for even emergent, unknown viruses and eliminate the lag time required to first identify and sequence the virus genetic material before we can treat it,” says Overall.
Find other stories about: Bruce McManus, Chris Overall, Dept. of Pathology and Laboratory Medicine, UBC Centre for Blood Research
Contact
Dr. Chris Overall
UBC Centre for Blood Research
Cell: 604.808.3587
E-mail: chris.overall@ubc.ca
Brian Lin
Senior Communications Coordinator
UBC Public Affairs
Tel: 604.822.2234
Cell: 604.818.5685
Email: brian.lin@ubc.ca
###
Public Affairs
310 - 6251 Cecil Green Park Road
Vancouver, BC Canada V6T 1Z1
Tel 604 822 6397
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsScientists Trying To Find Source Of Possible HIV Strain
AIDS scientists are studying viruses isolated from two people to find out if either of them are the source of a possibly more aggressive, drug resistant strain of HIV discovered in a local man. Dr. David Ho, director of…
15 February 2005
NewsScientists find clue to AIDS origins, new therapy
A single change in a human gene may hold the key to preventing people living with HIV from progressing to full-blown AIDS, researchers said on Monday. They found a crucial difference between a gene in humans and one in…
11 January 2005
NewsScientists find gene clue in hunt for AIDS vaccine
Scientists said on Wednesday they have identified key genes involved in the body's response to HIV, which causes AIDS - a finding that could narrow the search for an effective vaccine against the deadly illness. A…
